The Health Minister of New Zealand, David Cunliffe, has provided conditional approval to permit porcine cells to be transplanted into eight individuals with type 1 diabetes .
The treatments will form part of a clinical trial, conducted by Kiwi firm Living Cell Technologies. Living Cell Technologies are a pioneering company looking for ways to improve treatment for type 1 diabetics .
LCT are attempting a type of xenotransplantation, injecting the pig cells into type 1 diabetes patients to try and produce insulin in the body, thereby reducing the need for insulin injections .
Cunliffe took considerable advice before making his decision, and granted approval for the trial to go ahead at the Middle more Hospital in Auckland, subject to one further review.
Diabetes cell transplant approved in New Zealand
Tue, 21 Oct 2008
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes forum
Diabetes signs and symptoms
Diabetes chat
Diabetes drug treatment hope
Coffee and diabetes control
Pig cells for fighting diabetes live for ten years
Scientists change mouse cells to treat diabetes
Stem cells for diabetes investigated further
Diabetes cure closer due to Edinburgh stem cell breakthrough
Stem cell experts hold potential for diabetes cure
Diabetes stem cell research breakthrough
Stem cell research gives hope for diabetes, ADA say
Cell research could affect diabetes future
Importance of stem cell research for diabetes and other diseases
Pig cell diabetes treatment approved in New Zealand
Cell transplant breakthrough for diabetes
How are Islet cells affected by diabetes?
Pig cells diabetes breakthrough
Pioneering islet cell transplants again offer diabetes hope
Stem cell diabetes therapy
Pig cell treatment for diabetes
Diabetes cell breakthrough
Diabetes stem cell therapy effective
Stem cell isolation could have diabetes impact
Spleen cell research into diabetes
Sick fat cells could cause type diabetes
New hope for diabetes patients from cell transplant
Join us